Lab Revenue Modeling
Order Volume Audit to Financial Projection
$394K
Modeled annual revenue opportunity (2x commercial payer mix)
Client
Mobile Diagnostics Company
Date
March 2026
Service Line
Financial Intelligence / Revenue Systems
Context
The company was evaluating a new lab partnership and needed to understand: at current order volume, what revenue could they expect from lab services? The raw data existed across two disconnected systems — faxed order forms in email and a lab portal — but no one had translated order volume into revenue potential.
Impact
Test lines analyzed
Annual revenue (Medicare floor)
Annual revenue (1.5x blended payer mix)
Annual revenue (2x commercial mix)
Molecular panels: share of volume
Molecular panels: share of revenue
Time to produce model
The Pattern
Volume × Rate = Negotiating Leverage
Every healthcare service company considering a lab partnership or in-sourcing decision needs the same analysis: take observed order volume, map tests to CPT codes, look up payer-specific reimbursement rates, and model scenarios. The data usually exists but is trapped in email inboxes, portal dashboards, and PDF fax images. Once you have clean order data with test-level granularity, the revenue model is mechanical — and it reveals the Pareto insight that a handful of high-value molecular panels drive disproportionate revenue potential.
The same pattern applies to your business